|
ARHGAP12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.511800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.911800E-01 |
| Normal-vs-Stage2 |
2.020800E-01 |
| Normal-vs-Stage3 |
3.976600E-01 |
| Normal-vs-Stage4 |
4.750400E-01 |
| Stage1-vs-Stage2 |
1.416200E-01 |
| Stage1-vs-Stage3 |
2.419600E-01 |
| Stage1-vs-Stage4 |
4.073400E-01 |
| Stage2-vs-Stage3 |
5.863000E-01 |
| Stage2-vs-Stage4 |
5.933800E-01 |
| Stage3-vs-Stage4 |
9.541600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.950800E-01 |
| Normal-vs-AfricanAmerican |
9.925400E-01 |
| Normal-vs-Asian |
6.463700E-02 |
| Caucasian-vs-AfricanAmerican |
5.506400E-01 |
| Caucasian-vs-Asian |
1.275180E-03 |
| AfricanAmerican-vs-Asian |
1.856020E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.237400E-01 |
| Normal-vs-Female |
5.179200E-01 |
| Male-vs-Female |
3.008600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.627800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.156400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.321000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.562000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.907600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.661000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.483700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.715800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.463700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.550300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.541400E-01 |
| Classical-VS-Follicular |
5.604100E-04 |
| Classical-VS-Other |
8.776600E-01 |
| Classical-VS-Normal |
6.261400E-01 |
| Tall-VS-Follicular |
1.913380E-01 |
| Tall-VS-Other |
7.100400E-01 |
| Tall-VS-Normal |
5.981200E-01 |
| Follicular-VS-Other |
2.875800E-01 |
| Follicular-VS-Normal |
3.062200E-02 |
| Other-VS-Normal |
9.587600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.690180E-01 |
| Normal-vs-N1 |
7.466400E-01 |
| N0-vs-N1 |
9.199800E-02 |
|
|
